Mirjam Moerbeek
Overview
Explore the profile of Mirjam Moerbeek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
590
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moerbeek M
Behav Res Methods
. 2024 Sep;
56(8):8820-8830.
PMID: 39271634
In the cluster randomized crossover trial, a sequence of treatment conditions, rather than just one treatment condition, is assigned to each cluster. This contribution studies the optimal number of time...
2.
Moerbeek M
Behav Res Methods
. 2023 Dec;
56(6):5849-5861.
PMID: 38158552
In many studies in the social and behavioral sciences, the data have a multilevel structure, with subjects nested within clusters. In the design phase of such a study, the number...
3.
Alting van Geusau V, de Jongh A, Nuijs M, Brouwers T, Moerbeek M, Matthijssen S
Front Psychiatry
. 2023 Nov;
14:1278052.
PMID: 38025421
Background: Several widely studied therapies have proven to be effective in the treatment of post-traumatic stress disorder (PTSD). However, there is still room for improvement because not all patients benefit...
4.
Moerbeek M
PLoS One
. 2023 Aug;
18(8):e0289275.
PMID: 37585398
The cluster randomized stepped wedge design is a multi-period uni-directional switch design in which all clusters start in the control condition and at the beginning of each new period a...
5.
Bovendeerd B, de Jong K, de Groot E, Moerbeek M, Hafkenscheid A, de Keijser J
Clin Psychol Psychother
. 2023 Jun;
30(5):1146-1157.
PMID: 37278224
Objective: Therapist characteristics are known to affect treatment outcome in general and could also influence the use of systematic client feedback (SCF). The current study explores the effect of feedback...
6.
Moerbeek M
PLoS One
. 2023 Apr;
18(4):e0283382.
PMID: 37079588
The aim of a clinical trial is to compare placebo to one or more treatments. The within-subject design is known to be more efficient than the between-subject design. However, in...
7.
Kessels R, Moerbeek M
Biom J
. 2023 Apr;
65(5):e2200112.
PMID: 37068180
When observing data on a patient-reported outcome measure in, for example, clinical trials, the variables observed are often correlated and intended to measure a latent variable. In addition, such data...
8.
Moerbeek M
Clin Trials
. 2023 Feb;
20(3):242-251.
PMID: 36825509
Background/aims: The stepped-wedge design has been extensively studied in the setting of the cluster randomized trial, but less so for the individually randomized trial. This article derives the optimal allocation...
9.
Fu Q, Moerbeek M, Hoijtink H
Front Psychol
. 2022 Dec;
13:947768.
PMID: 36483714
Researchers can express their expectations with respect to the group means in an ANOVA model through equality and order constrained hypotheses. This paper introduces the R package SSDbain, which can...
10.
Kwee C, Baas J, van der Flier F, Groenink L, Duits P, Eikelenboom M, et al.
Eur Neuropsychopharmacol
. 2022 May;
59:58-67.
PMID: 35561538
Preclinical research suggests that enhancing CB1 receptor agonism may improve fear extinction. In order to translate this knowledge into a clinical application we examined whether cannabidiol (CBD), a hydrolysis inhibitor...